Habitrol Patch is a quick solution to quit smoking. With about 52.5 mg nicotine, it is your to-go nicotine stop smoking product. The patch also facilitates release of nicotine through day and night, for 24 hour quitting smoking.
Habitrol Patch is now accessible in three varying strengths – 7 mg, 14 mg, and 21 mg and three easy steps. You simply have to apply it on and nicotine is absorbed through your skin. By using the patch, you save yourself the risk of harmful toxin inhalation. Plus, you’ll remain free of second-hand smoke smell!
Habitrol patches are part of a carefully structured Habitrol support program including materials designed to provide you with information to help you stop smoking (see leaflet inside carton). Habitrol patches, being a step-down approach will reduce your nicotine dose gradually, rather than stopping suddenly. The program consists of 3 steps which you will need to follow. Each step has a specifically designed Habitrol patch that supplies your body with nicotine over a 24 hour period. The dose of nicotine delivered through the patch decreases as you go from Habitrol Step 1 through to Habitrol Step 3. Completing the entire program will increase your chance of quitting successfully. The step at which you start the program will depend on how many cigarettes you smoke each day. Each Habitrol patch can be worn for 24 hours so it works night and day.
Dose
For those smoking more than 20 cigarettes a day it is recommended that treatment be started with HABITROL Step 1 Patch. Those smoking less than 20 cigarettes a day should start with HABITROL Step 2.
Patients starting on HABITROL Step 1 should use this strength for 3 to 4 weeks, before moving onto Step 2 for 3 to 4 weeks, and finally Step 3 for 3 to 4 weeks.
Patients starting on HABITROL Step 2 may switch to Step 3 after 3 to 4 weeks, or continue to use Step 2 for 6 to 8 weeks before moving onto Step 3 for 3 to 4 weeks.
How quickly the patient moves through the program will vary depending on individual response, and maintaining or increasing the dose may be necessary if abstinence is not achieved or if withdrawal symptoms are experienced.
The treatment duration is about 3 months but may vary as a function of individual response. Intermittent dosing products (such as HABITROL Chewing Gum) may be used beyond 3 months if necessary, but those using NRT for more than 9 months should seek advice from a healthcare professional.
Instructions for use
HABITROL should be applied as soon as it has been removed from the see-through childresistant pouch. The sachet has a pre-cut edge to facilitate removal of the HABITROL Patch contents. Following removal of the metallic backing, the HABITROL Patch should be immediately applied to a clean non-hairy, dry area of intact skin on the trunk or upper arm. The patch should be held in position for 10-20 seconds with the palm of the hand. A different site of application should be chosen each day. One should allow several days to elapse before using the same area again.
Hands should be washed thoroughly after application of HABITROL Patch to avoid irritation of the eyes with nicotine from the fingers.
After removal, used patches should be disposed of carefully and kept out of sight and reach of children.
Please refer Medsafe Data Sheet for more details.
Ingredients
One Habitrol transdermal patch contains 52.5 mg of nicotine in a patch size of 30 cm2, releasing a nominal 21 mg of nicotine per 24 hours.
Excipients
Drug solution: Basic butylated methacrylate copolymer
External layer: Aluminium coated polyester foil
Matrix layer: Acrylate-vinylacetate copolymer, Triglycerides, medium-chain, Basic butylated methacrylate copolymer, Non-woven backing: Paper 26g/m2
Adhesive layer: Acrylate-vinylacetate copolymer, Triglycerides, medium-chain
Detachable protective film: Siliconised aluminized polyester film
Printing ink: Brown ink
Contraindications
HABITROL Patch should not be used for non-smokers or occasional smokers, children under 12 years of age, those with diseases of the skin (which may complicate patch therapy) or known hypersensitivity to nicotine or to any of the components of the therapeutic system